AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test

COHORT A Inclusion Criteria: * 50-84 years of age (inclusive) at the time of screening * Recently diagnosed with (or strong clinical suspicion for) primary colorectal cancer or advanced adenoma with plans to surgically or endoscopically remove the target lesion(s) * At least 7 days before but no more than 6 months after the most recent colonoscopy * Able and willing to provide blood and stool (optional) samples per protocol * Able to comprehend and willing to sign and date the written informed consent document(s) and any applicable medical record release documents for the study Key Exclusion Criteria: * Personal history of colorectal cancer, colorectal adenomas (excluding non-adenomatous (e.g., hyperplastic polyps)) or aerodigestive tract cancer (other than most recent diagnosis) * Colonoscopy within the previous 9 years (other than most recent diagnosis) * Overt rectal bleeding within the previous 30 days * Have a medical condition which, in the opinion of the investigator, should preclude enrollment into the study. * Have participated or be currently participating in a clinical research study in which an experimental medication has been administered during the 60 days up to and including the date of providing informed consent or may be administered through the time of the colonoscopy. * If female, known to be pregnant. COHORT B Inclusion Criteria: * 50-84 years of age (inclusive) at the time of screening * Planning to undergo a screening colonoscopy within 75 days after providing signed informed consent * Able and willing to provide blood and stool (optional) samples per protocol * Able to comprehend and willing to sign and date the written informed consent document(s) and any applicable medical record release documents for the study Key Exclusion Criteria: * Personal history of colorectal cancer, colorectal adenoma (excluding non-adenomatous (e.g., hyperplastic polyps)) or aerodigestive tract cancer * Colonoscopy within the previous 9 years * Overt rectal bleeding within the previous 30 days * Have a medical condition which, in the opinion of the investigator, should preclude enrollment into the study. * Have participated or be currently participating in a clinical research study in which an experimental medication has been administered during the 60 days up to and including the date of providing informed consent or may be administered through the time of the colonoscopy. * If female, known to be pregnant. COHORT C Inclusion Criteria: * At least 18 years of age (inclusive) at the time of screening * Recently diagnosed with (or strong clinical suspicion for) primary colorectal cancer or advanced adenoma with plans to surgically or endoscopically remove the target lesion(s) * At least 7 days before but no more than 6 months after the most recent colonoscopy * Able and willing to provide blood and stool (optional) samples per protocol * Able to comprehend and willing to sign and date the written informed consent document(s) and any applicable medical record release documents for the study Exclusion Criteria: * Have a medical condition which, in the opinion of the investigator, should preclude enrollment into the study. * Have participated or be currently participating in a clinical research study in which an experimental medication has been administered during the 60 days up to and including the date of providing informed consent or may be administered through the time of the colonoscopy. * If female, be known to be pregnant.